ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

October 29, 2004

DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy

May 27, 1988

In Brief: Comprehensive Centers “Jewel In Crown” Of Cancer Program, DeVita Says; Boutwell New NCAB Member

February 18, 1983

DCT board Oks New Cooperative Groups For MRI Evaluations In Breast Cancer

February 18, 1994

MSKCC Asked To Repay $638,371 To NIH

December 13, 1985

In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding

June 24, 1994